There is a huge demand for Remdesivir injection in the country amid increasing cases of corona. At this time it is being sold in Kalabazar for more than 50 thousand rupees but its price is between 3000-5000. The only reason for this is that its demand is very high while the supply is very less. Meanwhile, Biocon chief Kiran Mazumdar Shaw said that till the third week of May, there will be no shortage of this injection in the country. He said that Itolizumab and Tocilizumab will also be abundantly available in the market by the first week of June.
Biocon is one of the leading Indian companies making these drugs. The drug Remdesivir is used only on the instructions of the doctor and should also be used. It is used on patients severely affected by corona. Itolizumab and tocilizumab are used predominantly on patients who show symptoms of cytokine storm that are due to corona.
Talking to The Times of India, Kiran Mazumdar Shaw said that the demand for these three drugs has increased a lot while the inventory is very low. I hope that by the third week of May, there will be a significant stock of Remedisvir in the country. Demand for Itolizumab has also been recorded very high. In spite of the demand, the company has accelerated the production, yet it is still low. Biocon is the only company in the world to manufacture Itolizumab due to which there is a huge difference in demand and supply. Majumdar Shaw said that we have increased production three times while demand has increased 10 times.
read this also,
read this also,
The postappeared first on .